326 related articles for article (PubMed ID: 20506127)
1. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.
Hovinga KE; Shimizu F; Wang R; Panagiotakos G; Van Der Heijden M; Moayedpardazi H; Correia AS; Soulet D; Major T; Menon J; Tabar V
Stem Cells; 2010 Jun; 28(6):1019-29. PubMed ID: 20506127
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
[TBL] [Abstract][Full Text] [Related]
3. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
Kristoffersen K; Villingshøj M; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2013 Jul; 14(7):625-37. PubMed ID: 23792644
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
5. The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network.
Gürsel DB; Berry N; Boockvar JA
Neurosurgery; 2012 Feb; 70(2):N19-21. PubMed ID: 22251985
[No Abstract] [Full Text] [Related]
6. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
[TBL] [Abstract][Full Text] [Related]
7. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
[TBL] [Abstract][Full Text] [Related]
8. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
9. Organotypic explant culture of glioblastoma multiforme and subsequent single-cell suspension.
Shimizu F; Hovinga KE; Metzner M; Soulet D; Tabar V
Curr Protoc Stem Cell Biol; 2011 Dec; Chapter 3():Unit3.5. PubMed ID: 22135084
[TBL] [Abstract][Full Text] [Related]
10. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres.
Natsumeda M; Maitani K; Liu Y; Miyahara H; Kaur H; Chu Q; Zhang H; Kahlert UD; Eberhart CG
Brain Pathol; 2016 Nov; 26(6):713-723. PubMed ID: 26613556
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
[TBL] [Abstract][Full Text] [Related]
12. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Debeb BG; Cohen EN; Boley K; Freiter EM; Li L; Robertson FM; Reuben JM; Cristofanilli M; Buchholz TA; Woodward WA
Breast Cancer Res Treat; 2012 Jul; 134(2):495-510. PubMed ID: 22547109
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell-vascular endothelial cell interactions in glioblastoma.
Sharma A; Shiras A
Biochem Biophys Res Commun; 2016 May; 473(3):688-92. PubMed ID: 26692486
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
[TBL] [Abstract][Full Text] [Related]
15. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
[TBL] [Abstract][Full Text] [Related]
16. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
17. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells.
Sherry MM; Reeves A; Wu JK; Cochran BH
Stem Cells; 2009 Oct; 27(10):2383-92. PubMed ID: 19658181
[TBL] [Abstract][Full Text] [Related]
18. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
19. Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells.
Rajakulendran N; Rowland KJ; Selvadurai HJ; Ahmadi M; Park NI; Naumenko S; Dolma S; Ward RJ; So M; Lee L; MacLeod G; Pasiliao C; Brandon C; Clarke ID; Cusimano MD; Bernstein M; Batada N; Angers S; Dirks PB
Genes Dev; 2019 May; 33(9-10):498-510. PubMed ID: 30842215
[TBL] [Abstract][Full Text] [Related]
20. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
